HomeNewsWorldDomestic air travel down 70%, recovery likely to be slow: IATA

Domestic air travel down 70%, recovery likely to be slow: IATA

While domestic markets will open sooner than long-haul, the damage done to consumer confidence will undermine a quick recovery, Brian Pearce, chief economist with the International Air Transport Association, told journalists on a conference call.

April 21, 2020 / 20:05 IST
Story continues below Advertisement

Domestic air traffic is down 70 percent globally and the recovery over the coming six months is likely to be slow due to the damage coronavirus has done to economic conditions, the industry's representative body IATA said on Tuesday.

While domestic markets will open sooner than long-haul, the damage done to consumer confidence will undermine a quick recovery, Brian Pearce, chief economist with the International Air Transport Association, told journalists on a conference call.

Story continues below Advertisement

"The economic environment that we are expecting over the next six months is really not conducive to any substantial return to air travel for financial reasons... which is why we are expecting to see that recovery in the third quarter to be relatively modest," Pearce said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show